VSA003

· Visirna Therapeutics HK Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VSA003, covering 2024-12-02 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers [Phase 1]